EE625 Cost-Effectiveness Analysis of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) to Prevent Pneumococcal Disease in the Greek Pediatric Population

Autor:	Tzanetakos, C 1, Kokkinaki, I 2, Barmpouni, M 2, Kossyvaki, V 2, Psarra, M 1, Perdrizet, J 3, Gourzoulidis, G 1
Zdroj:	In Value in Health December 2024 27(12) Supplement:S178-S178
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect